2. Investors

INVESTOR RELATIONS

For more than two decades, RaySearch Laboratories has created value by advancing cancer treatment through software innovation. We aim to keep you informed about our performance and other factors relevant to your assessment of RaySearch as an investment.

RAYSEARCH'S YEAR-END REPORT 2025

RaySearch published its year-end report for 2025 on Thursday, February 12. A webcast presentation was held the same day.

Webcast presentation

Key figures (rolling 12m)

Latest press releases

First patient treated in Ukraine using RayStation

Year-end report 2025: Record revenue and strong earnings growth despite currency headwinds

The Royal Marsden NHS Foundation Trust uses RayStation for online adaptive treatments with conventional C-arm linacs

All press releases

Financial Calendar

See full calendar

The Share

The share

Subscribe

IR contact